Safety and efficacy of paramedic treatment of regular supraventricular tachycardia
Para-SVT
Safety and efficacy of paramedic treatment of regular supraventricular tachycardia Para-SVT Victoria Baker, Mark Whitbread, Laura Richmond, ...
Safety and efficacy of paramedic treatment of regular supraventricular tachycardia Para-SVT Victoria Baker, Mark Whitbread, Laura Richmond, Claire Kirkby, Gemma Robinson, Sotiris Antoniou, Richard Schilling
caused by an electrical reentry circuit which uses the AV node as part of the circuit quite common with a prevalence of 2.29/1000 persons can be stopped by injecting Adenosine a drug which temporarily blocks electrical induction in the AV node
Secondary information
Para-SVT Introduction Paramedic treatment of supraventricular tachycardia In the UK
Perform valsalva Transfer to nearest accident & emergency department
In the USA
Adenosine can be administered by Paramedic at the scene Patient is then transferred to nearest emergency department
Secondary information
Para-SVT Introduction Aim
To compare current UK practice with Paramedic treatment and discharge of patients with regular supraventricular tachycardia without transfer to an accident and emergency department
Primary end-point The cumulative time from 999 call to discharge from care for each episode of arrhythmia at 6 month follow-up Secondary end-points Complications of treatment Accuracy of ECG diagnosis of supraventricular tachycardia by Paramedic Number of patients refusing or unable to complete Paramedic treatment arm At 6 months number of antiarrhythmic medications being taken At 6 months number of patients who have seen a heart rhythm specialist At 6 months number of patients with continuing symptoms
Secondary information
Para-SVT Methods
All patients presenting with a regular narrow complex tachycardia as their primary complaint are screened by the attending paramedic
Secondary information
Para-SVT Inclusion / Exclusion criteria Inclusion criteria Regular narrow complex tachycardia on 12 lead ECG Exclusion criteria Age < 16 years Syncope or blackout Inability or unwillingness to give consent ECG evidence of myocardial infarction Pregnancy Failure to obtain intravenous access Contraindications to Adenosine injection Heart transplant patients Patients on Dipyridamole Patients on regular asthma inhalers
Secondary information
Already enrolled in the study or another research study A history of illicit drug use within the previous 24 hours Sinus tachycardia Broad Complex tachycardia Hypotension (